254 related articles for article (PubMed ID: 16051460)
1. Extended lymphadenectomy (D2) in patients with early gastric cancer.
Nitti D; Marchet A; Mammano E; Ambrosi A; Belluco C; Mencarelli R; Maino M; Marconato G; Farinati F; Lise M
Eur J Surg Oncol; 2005 Oct; 31(8):875-81. PubMed ID: 16051460
[TBL] [Abstract][Full Text] [Related]
2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
3. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
5. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
6. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.
Pugliese R; Maggioni D; Sansonna F; Ferrari GC; Forgione A; Costanzi A; Magistro C; Pauna J; Di Lernia S; Citterio D; Brambilla C
Eur J Surg Oncol; 2009 Mar; 35(3):281-8. PubMed ID: 18342480
[TBL] [Abstract][Full Text] [Related]
8. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoma: does lymph node dissection alter survival?
Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
11. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
[TBL] [Abstract][Full Text] [Related]
12. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
13. Application of minimally invasive treatment for early gastric cancer.
Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
[TBL] [Abstract][Full Text] [Related]
14. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
[TBL] [Abstract][Full Text] [Related]
15. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and long-term results of surgical therapy of early gastric cancer].
Hou PF; Zhang XF; Zheng ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):53-6. PubMed ID: 17253175
[TBL] [Abstract][Full Text] [Related]
18. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
Putchakayala K; Difronzo LA
Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
[TBL] [Abstract][Full Text] [Related]
19. Choice of the surgical treatment in early gastric cancer.
Custureri F; D'Orazi V; Peparini N; Gabatel R; Urciuoli P; Patrizi G; Redler A; Di Matteo G
Hepatogastroenterology; 2004; 51(58):1210-4. PubMed ID: 15239281
[TBL] [Abstract][Full Text] [Related]
20. [Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study].
Roviello F; Marrelli D; Morgagni P; De Manzoni G; Di Leo A; Vindigni C; Nastri G; Saragoni L; Tomezzoli A; Kurihara H; De Stefano A
Chir Ital; 2003; 55(4):491-8. PubMed ID: 12938593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
